Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Vosoritide by BioMarin Pharmaceutical for Dwarfism: Likelihood of Approval
Vosoritide is under clinical development by BioMarin Pharmaceutical and currently in Phase III for Dwarfism. According to GlobalData, Phase III...